FDA Inspection 1191849 — Pharmacy Innovations

Pharmacy Innovations — FEI 3004858203

The FDA completed an inspection of Pharmacy Innovations on November 30, 2022 in Erie, PA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 30, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Erie, PA (United States)